Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × blinatumomab × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Burkitt Lymphoma 10 Leukemia, Biphenotypic, Acute 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm, Residual 3 Leukemia 3 Recurrence 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphoid 1 Hematologic Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 26 fludarabine 18 Rituximab 13 obinutuzumab 10 Bendamustine Hydrochloride 9 venetoclax 7 Lenalidomide 7 pembrolizumab 5 Prednisone 5 Exercise 5 zanubrutinib 4 fludarabine phosphate 4 Mesna 4 Etoposide 4 Doxorubicin 4 Cytarabine 4 Blood Specimen Collection 4 Biopsy 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 Vincristine 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Radiotherapy 3 Palliative Care 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07294677 2026-03-04

CAVALRY

University of Chicago

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡